Immune cells within tertiary lymphoid structures are associated with progression-free survival in patients with locoregional recurrent breast cancer.
Jinyuan GuJiaming WangYue SunXinrui MaoChao QianXinyu TangJi WangHui XieLijun LingYi ZhaoXiaoan LiuKai ZhangHong PanShui WangCong WangWenbin ZhouPublished in: Cancer medicine (2023)
Our study proposes potential predictors for the clinical prognosis of patients with locoregional recurrent breast cancer, emphasizing the prognostic value of immune cells within TLSs, especially CD68+ cells.